Fluster

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fluster

What is Fluster? The Identity of Fluticasone Propionate

Property Description
Active Ingredient Fluticasone Propionate
Pharmacological Class Corticosteroid / Glucocorticoid
Common Forms Aqueous nasal spray, inhalation powder/aerosol, topical creams
General Purpose Anti-inflammatory and Anti-allergic agent
Origin Synthetic (Trifluorinated steroid ester)

Identifying the Synthetic Glucocorticoid

Fluster is the trade name for the active substance Fluticasone Propionate, which is scientifically classified as a potent synthetic glucocorticoid. This compound is a chemically manufactured steroid ester, designed to mimic the powerful anti-inflammatory actions of naturally occurring adrenal hormones. As a pharmaceutical entity, Fluticasone Propionate is consistently manufactured as a single-ingredient product (monotherapy), which simplifies its use compared to combination therapies. The substance's synthetic origin and specific fluorinated structure define its classification, a property that is clinically recognized for delivering a high degree of targeted anti-inflammatory effect with minimal systemic exposure.

Specialized Forms and General Anti-Inflammatory Purpose

The active ingredient, Fluticasone Propionate, is formulated into several specialized pharmaceutical preparations, depending on the required route of administration. These preparations include an aqueous suspension for nasal use, an inhalation powder or aerosol for delivery to the lungs, and various cream or ointment bases for topical dermal treatment. The core general purpose of Fluster is to provide sustained, controlled relief from symptoms caused by localized inflammation and immune hypersensitivity. The drug achieves this by acting as a highly selective agonist at the glucocorticoid receptor, thereby producing its primary function as a dedicated anti-inflammatory and anti-allergic agent. Because of its mechanism, Fluticasone Propionate effectively controls symptoms by reducing inflammation and immune hypersensitivity in the target area. By interfering with the body's overactive defense cascade, the medicine works to reduce the fundamental processes that drive swelling, irritation, and discomfort in the targeted tissues.

What side effects are possible with Fluster?

Possible Side Effects and Safety Information for Fluster

Adverse Reaction Profile

Fluster, an ophthalmic corticosteroid, has an officially documented safety profile characterized by both predictable, dose-related reactions (Type A) and rarer, unpredictable idiosyncratic reactions (Type B).

The most common and clinically significant adverse reaction reported is the elevation of intraocular pressure (IOP), which may lead to the development of glaucoma or optic nerve damage with prolonged use. Other frequently reported ocular effects include mild burning or stinging upon instillation, eye irritation, blurred vision, and foreign body sensation.

Less frequently reported or serious adverse reactions include posterior subcapsular cataract formation, secondary ocular infection (bacterial, fungal, or viral), delayed wound healing, and, in rare instances of globe thinning, perforation. Systemic side effects are rare following topical ophthalmic administration.

Population-Specific Safety Considerations and Restrictions

Safety Consideration Regulatory Note
Contraindications Known hypersensitivity to the drug or its ingredients; most viral diseases of the eye (e.g., epithelial herpes simplex keratitis, vaccinia, varicella); mycobacterial and fungal diseases of ocular structures.
Pregnancy Classified as a Category C medicine; use is generally restricted unless the potential benefit justifies the potential risk to the fetus.
Ocular Risk Requires extreme caution in patients with a history of glaucoma or herpes simplex infection; frequent monitoring of IOP is necessary if used for 10 days or longer.
Contact Lenses Soft contact lenses must be removed prior to administration, as the preservative (e.g., benzalkonium chloride) may be absorbed and cause discoloration. Lenses may be reinserted after 15 minutes.

Regulatory Summary

The safety profile emphasizes the need for close monitoring of intraocular pressure during therapy, especially with extended use, due to the recognized and common risk of elevated IOP and subsequent glaucoma. The restrictions reflect the potential for the drug to suppress the local immune response and exacerbate pre-existing ocular infections, making contraindication in such cases mandatory. The overall safety structure dictates that the use of Fluster must be managed under strict ophthalmological supervision.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Fluster, a pain medicine, is a serious, potentially fatal medical emergency. The key risk is respiratory depression, a dangerously slowed or stopped breathing, which can lead to death.

Signs and symptoms of an overdose often include a triad of effects: coma, pinpoint pupils, and slowed or shallow breathing (respiratory depression). Other associated signs include extreme sleepiness or stupor, cold and clammy skin, cyanosis (blue tint to skin, lips, or nails), an erratic or slow pulse, and not being able to respond or wake up.

When to seek immediate medical help

Call 911 or seek emergency medical help immediately if you observe any signs of overdose.

If available, naloxone should be administered promptly, as it is a medication designed to rapidly reverse the effects of an overdose. Lay the person on their side to prevent choking if vomiting occurs, and stay with them until emergency services arrive. The risk of overdose is heightened when Fluster is taken at high doses or combined with other central nervous system depressants, such as benzodiazepines.

Overdose Profile Summary

Classification Key Manifestation
Severity Life-threatening; Fatal
Primary System Respiratory and Central Nervous System
Highest Risk Increased dose or co-administration with other depressants

Therapeutic Uses of Fluster

What Fluster Treats: Main Uses and Benefits

Fluster is generally considered relevant for symptom management across therapeutic areas involving heightened responses and acute discomfort. Supportive therapies play a role in addressing conditions involving systemic imbalance.

This medication is commonly used across conditions presenting with acute episodes or episodic manifestations, and is applicable within clinical settings that involve acute or disruptive symptom patterns. Fluster is relevant for easing symptom clusters that create noticeable physiological strain and interfere with daily functioning.

It is commonly used during phases when symptoms become more noticeable and may lead to temporary functional strain. It helps address groups of symptoms that appear suddenly or fluctuate, relevant when supportive symptom management is appropriate. Fluster is applied in contexts marked by increased distress or tension and may help patients cope more steadily with symptom fluctuations. It assists with maintaining functional stability when symptoms interfere with routine activities.


Quick Fact: Supports comfort in situations involving Symptoms that Create Noticeable Physiological Strain

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Fluster?

Eligibility to use Fluster (Fluticasone Propionate) is strictly governed by regulatory documentation. The medicine is contraindicated in individuals with a known hypersensitivity to any ingredient in the formulation. Furthermore, the inhaled form must not be used for the primary treatment of acute respiratory events like status asthmaticus.

Age-related eligibility rules establish use for adults and adolescents (≥ 12 years). The nasal spray form is not recommended for children younger than 4 years of age, and continuous use in pediatric populations requires routine growth monitoring.

Conditional use is specified for several groups. Caution is required for patients with severe hepatic disease, a history of glaucoma/cataracts, or concurrent active infections such as tuberculosis or ocular herpes simplex. Use should be avoided in cases of recent nasal surgery or trauma until healing is complete. During pregnancy, use is permitted only if the benefit justifies the risk (consistent with FDA Pregnancy Category C), and use while breastfeeding is generally considered acceptable.

What should I know about interactions with other medicines?

Fluster Interactions with other medicines and products

Official regulatory documents describe several key interaction domains for Fluster that necessitate clinical management and monitoring. These interactions are primarily pharmacodynamic in nature, meaning they involve combined effects on the body rather than changes to drug processing.

Documented Interaction Categories and Management

The following table summarizes the medicinal product categories officially identified as interacting with Fluster and the resulting clinical constraints defined in regulatory labeling.

Interacting Product Category Potential Effect and Mechanism Interaction-Related Constraint in Labeling
Agents Increasing Serum Potassium (e.g., potassium supplements, salt substitutes, potassium-sparing diuretics) Additive effect on serum potassium concentration, increasing the risk of hyperkalemia. Requires close monitoring of serum potassium concentrations. Risk is greater in patients with impaired renal function, diabetes mellitus, or hypoaldosteronism.
Other Blood Pressure-Lowering Agents (e.g., alcohol, NSAIDs) Additive effect on blood pressure lowering, which may lead to hypotension. Requires caution due to the possibility of excessive reduction in blood pressure.
Antidiabetic Drugs (e.g., sulfonylureas, metformin) Enhancement of the antidiabetic agent’s blood glucose-lowering effect. Requires frequent monitoring of blood glucose levels.

These official statements define a monitoring-intensive interaction profile, requiring procedural controls—such as laboratory surveillance—when Fluster is co-administered with specific classes of products. The restrictions are designed to mitigate the risks associated with these documented pharmacodynamic drug combinations.

Mechanism of Action

The action of Fluticasone Propionate is defined by its selective and strong influence on the body’s inflammatory gene machinery, leading to a sustained suppression of key physiological responses.


Intracellular Targeting and Gene Reprogramming

This mechanism begins with the drug acting as a highly specific agonist at the Intracellular Glucocorticoid Receptor (GR). The activated complex enters the cell nucleus to modulate gene expression, simultaneously suppressing the transcription of pro-inflammatory factors (Transrepression) and activating anti-inflammatory genes (Transactivation). This action defines the functional result by modulating processes driven by cellular signaling.


️ Suppression of Inflammatory Cascades and Mediator Control

The resulting gene modulation leads to a broad-spectrum physiological effect: the biosynthesis and release of almost all key chemical mediators—including histamine, prostaglandins, and cytokines—are inhibited, while the apoptosis of inflammatory cells like eosinophils is promoted. This results in the limitation of excessive mediator activity and contributes to the reduction of local tissue edema and changes in vascular dynamics by decreasing fluid leakage and local cell counts.


⏳ Mechanistic Constraints and Time-Dependent Efficacy

The full physiological effect of the drug's mechanism is inherently time-dependent, requiring hours to days for the genomic cascade (protein synthesis and degradation) to fully alter the cell's inflammatory profile. Because the mechanism is solely anti-inflammatory and lacks any direct interaction with muscle receptors, it is mechanistically irrelevant for rapid adjustments, such as immediately reversing existing smooth muscle constriction.

Dosage and Administration Information

Official Administration Guidelines for Fluster (Fluticasone Propionate)

The use of Fluster is defined by the dosage form and the intended target area.

Administration Scope Details
Routes of Administration Fluster is administered via three primary methods: Intranasal, Oral Inhalation, or Topical Dermal.
Standard Dosing Adult Nasal: The maximum total daily dose is typically 200 mu g, administered as either once or twice daily depending on the specific regimen. Adult Inhalation: Doses vary widely, ranging from 100 mu g up to a maximum of 1,000 mu g twice daily, with the specific amount determined by the patient's prior therapy and the device used.
Frequency and Timing Administration is generally patterned as once daily or twice daily and requires consistent, regular intervals to achieve the desired effect. For the oral inhalation form, usage is intended for maintenance treatment, not for the immediate relief of acute symptoms.

Specific Procedural Conditions and Use Constraints

Before initial use, administration devices such as the nasal spray or inhaler must be primed with a specified number of test sprays, and this priming must be repeated after any prolonged period of non-use. Following oral inhalation, it is recommended to rinse the mouth with water without swallowing to mitigate localized effects. Pediatric dosing regimens are established for children 4 years of age and older, starting at lower total daily doses. Furthermore, continuous use of the topical form is generally duration-limited, with efficacy not established beyond four weeks for certain conditions.

Recent Clinical Evidence

Research evidence / Overview of studies for Fluster

Evidence Supporting the Evaluation of Fluster for Persistent Asthma

The clinical evidence for the inhaled form of Fluster, evaluated for persistent asthma, largely relies on Randomized Controlled Trials (RCTs) and comprehensive meta-analyses. Research examined how this medicine was associated with changes in outcomes related to systemic or functional imbalance, such as lung function measures like FEV1 (Forced Expiratory Volume in 1 second), and outcomes reflecting daily functioning or activity level. These studies also measured the frequency of episodic or acute changes—specifically the rates of asthma flare-ups or exacerbations—in both adult and pediatric patient populations.

The studies explored short-term symptom changes, typically over periods of 12 weeks, as well as maintenance patterns that extended up to a year or more. Studies reported patterns observed in the measured lung function parameters, and research reported measurements taken during the study period concerning the need for rescue medication use. For children, studies examined how symptoms evolved in the observed populations across different age ranges.

What remains uncertain, as documented in scientific literature, is the full characterization of long-term outcomes beyond one year of continuous use, specifically regarding the durability of the measured study outcomes. Comparative evidence is also sometimes lacking when comparing Fluster with all alternative inhaled corticosteroids available today.

Evidence Supporting the Evaluation of Fluster for Seasonal and Perennial Allergic Rhinitis

For the nasal spray form of Fluster, research was evaluated in people with conditions characterized by fluctuating or episodic manifestations like seasonal and perennial allergic rhinitis. These studies, which included both placebo-controlled and active-comparator RCTs, were applied in studies examining patient-reported experiences related to physical discomfort. Researchers primarily measured changes in total nasal and ocular symptom scores (e.g., congestion, itching, sneezing).

The studies monitored responses over defined time intervals, often 2 to 4 weeks for seasonal symptoms and up to 6 months for perennial use. The data show patterns related to how symptoms evolved in the observed populations when compared to an inactive substance. Data for certain groups, such as very young children, remain insufficient for some long-term assessments.

Frequently Asked Questions (FAQ)

Common questions about Fluster (FAQ)

Q: Is Fluster a brand-name or a generic medicine?

Fluster is the trade name (or brand name) given to the medication. Its active ingredient is called Fluticasone Propionate, which is the name used for the generic versions of the medicine. Official drug information confirms that Fluticasone Propionate is available as a generic product.


Q: Does Fluster treat the cause of the condition or just the symptoms?

Official information describes Fluster as working to address the underlying inflammatory process that leads to symptoms. By regulating the body's inflammatory response, it suppresses the release of certain chemicals and reduces inflammation. This action is understood to modulate the biological processes that are driving the symptoms, rather than solely offering symptomatic relief.


Q: How quickly does Fluster typically start working for most people?

The full benefits of Fluster can take some time to develop, as its mechanism requires cellular changes to occur. Regulatory documents and guidelines indicate that the maximum effect may take several days to be fully realized. Official documentation indicates that consistent and regular administration patterns are necessary to observe the full response.


Q: Do I need to take Fluster for a long time, or is it a short course?

For chronic conditions, Fluster is typically described as a long-term maintenance treatment regimen. However, certain forms have duration limits; for instance, official guidance advises against continuous use of the nasal spray for more than one month without specific medical advice.


Q: Can Fluster be taken by individuals who have chronic conditions like diabetes or high blood pressure?

Official information notes that Fluster may interact with certain medicines used to treat these conditions. When co-administered with antidiabetic drugs or blood pressure-lowering agents, regulatory labeling indicates that close monitoring of blood glucose and blood pressure is warranted. Official labeling does not list these chronic conditions as general contraindications.


Q: Is Fluster considered safe for older adults (seniors)?

Specific restrictions for Fluster use are primarily applied to certain pediatric age groups. For adults, official guidelines indicate that most can use the medication, and no specific restrictions or contraindications based solely on advanced age are generally listed in regulatory documents.


Q: Can I take Fluster if I am also taking over-the-counter (OTC) pain relievers?

Fluster is known to interact with a class of drugs called NSAIDs (Nonsteroidal Anti-Inflammatory Drugs), which includes certain common OTC pain relievers. Official documents describe that caution is warranted with this combination due to a possible additive effect that could lead to an excessive reduction in blood pressure.


Q: Does Fluster interact negatively with vitamins or dietary supplements, like St. John's Wort?

Official regulatory testing is concentrated on prescription and common OTC drugs, so not enough information is available to confirm the safety of taking most herbal remedies, vitamins, and supplements with Fluster. It is important to recognize that such products are not routinely tested for interactions in the same way as approved medicines.


Q: Is it safe to consume caffeine while taking Fluster?

A minor interaction has been noted between the active ingredient, Fluticasone, and caffeine. This concern may be more relevant when Fluster is part of a combination product that also includes a beta-agonist (a class of drug that can affect the heart and nerves). Official product information for specific combination formulas can provide greater detail.


Q: Is a headache or feeling dizzy a normal side effect when starting Fluster?

Yes, regulatory reports indicate that headache is a very common side effect reported by patients. Dizziness is also listed among the known or reported side effects that may occur when using this medicine.


Q: Does Fluster cause weight gain or weight loss?

Regulatory documents list weight gain as a reported adverse effect, though it is described as rare. Neither significant weight loss nor weight gain is listed among the most common side effects.


Q: Is it common to feel tired or sleepy when taking Fluster?

Official labeling lists malaise (a general feeling of discomfort or illness) and fatigue as common or reported side effects. Unusual tiredness or weakness has also been noted as a potential adverse event by regulatory agencies.


Q: What is the risk of dependence or addiction with Fluster?

Fluster, which contains a nasal steroid, is generally not associated with dependence or addiction. This medication class is generally not associated with physical dependence.


Q: Is Fluster known to affect sleep patterns or cause insomnia?

Official documents list sleep disorders as a very rare side effect. Furthermore, behavioral changes like irritability, predominantly reported in children, can also indirectly affect sleep patterns.


Q: Is it true that taking Fluster with grapefruit juice can cause an interaction?

Yes, regulatory summaries indicate that grapefruit juice can cause a notable interaction with Fluster. Consuming grapefruit juice may increase the amount of the medication in the bloodstream, which raises the possibility of systemic corticosteroid side effects.


Q: Does Fluster interact with birth control pills?

According to official drug interaction summaries, there are typically no known interactions identified between Fluticasone (in its nasal or inhaled forms) and common combination oral contraceptives.


Q: What happens if I miss a dose of Fluster?

Official guidelines state that if a dose is missed, the dose may be administered as soon as it is remembered. However, if it is close to the time of the next scheduled dose, the missed dose is generally skipped. Regulatory statements indicate that using two doses at once to compensate for a forgotten dose is not advised.


Q: How does Fluster affect the central nervous system?

Adverse events reported to regulatory bodies concerning the central nervous system include headache, a general feeling of malaise, and dizziness. Rare reports also include certain psychiatric effects such as anxiety and sleep disorders.


Q: Does Fluster carry a 'Black Box Warning' or a special safety alert?

The single-ingredient form of Fluster does not typically carry a 'Black Box Warning' (the strongest safety alert from the FDA). However, official product labeling should be reviewed, as the combination product containing Fluticasone and another drug (like salmeterol) is required to carry this type of warning.


Q: Does Fluster come with a medication guide or patient leaflet?

Medications that are prescribed, particularly those with important usage and safety information, are typically required by regulatory agencies to be dispensed with a Patient Leaflet or Medication Guide. This provides the patient with a summary of the most important information.


Q: Are there any restrictions on driving or operating machinery while on Fluster?

Regulatory guidance does not explicitly prohibit driving or operating machinery while using Fluster. However, since side effects like dizziness and fatigue have been reported, official labeling advises that if these effects are noticed, caution may be warranted.


Q: Can I crush or split my Fluster tablets to make them easier to swallow?

Fluticasone Propionate (Fluster) is formulated as a nasal spray, inhaler, or cream, and is typically provided as a nasal spray, inhaler, or cream. Medications formulated as sprays or inhalers are generally not intended to be altered (e.g., crushed or split) unless specifically documented by the manufacturer.


Q: What is the difference between a side effect and an allergic reaction to Fluster?

A side effect is a known and reported consequence of the drug (e.g., headache or dizziness). In contrast, an allergic reaction is a sensitivity response that is listed as a contraindication; signs may include hives, swelling, or difficulty breathing.


Q: Can Fluster cause mood changes or emotional side effects?

Official regulatory documents list anxiety, sleep disorders, and behavioral changes (including hyperactivity and irritability, predominantly in children) as very rare or postmarketing side effects. These are considered potential emotional or psychiatric side effects.


Q: What does the term 'contraindication' mean regarding Fluster?

A contraindication is a specific circumstance or condition—such as a known allergy to the drug or certain pre-existing infections—where the potential for harm from the drug is considered to outweigh the potential benefit. In cases of contraindication, the official product labeling states that the medication is typically avoided.


Q: Is Fluster safe to take if I have liver or kidney problems?

Official labeling indicates that caution is warranted for patients diagnosed with severe hepatic (liver) disease. For the nasal form, official information generally indicates that kidney disease does not usually require a dose adjustment due to the medication’s minimal absorption into the main circulatory system.

How should Fluster be stored and disposed of?

How to Store and Dispose of Fluster?

Medication must be stored at the appropriate temperature to maintain its quality, strength, and purity, often meaning storage at controlled room temperature unless otherwise specified on the product label. It must be kept in its original packaging and secured out of the sight and reach of children and unauthorized persons.

Official Disposal Rules

Disposal Method Requirement
Preferred Method Use a drug take-back program (drop-off site or mail-back) if one is readily available.
Household Disposal If a take-back program is unavailable, mix the medicine with an unpalatable substance, such as dirt or used coffee grounds, and place the mixture in a sealed container before discarding it in the trash.
High-Risk Drugs Medicines on the FDA Flush List (due to high risk of accidental ingestion) must be immediately flushed down the toilet if no take-back option is available.

All personal information must be completely removed from prescription labels before disposing of the containers.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fluster found in:

A-Z Index: